Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Tilpas mikro-randomiseret forsøg (ADAPT MRT)

22. september 2026 opdateret af: Pedja Klasnja, University of Michigan

The goal of this study is to collect quantitative and qualitative data that can be used to optimize the HeartSteps mHealth intervention for physical activity. The current version of the intervention is intended to help patients with heart disease increase and maintain their physical activity long-term. To accomplish this goal, a 3-month pilot micro-randomized trial (MRT) will be conducted with 60 patients who are currently completing or have recently completed phase II cardiac rehabilitation (CR).

The core of the study participation is the use of the HeartSteps intervention over the course of 3 months. This includes wearing the Fitbit Charge activity tracker during waking hours and using the HeartSteps intervention to support their efforts to be active. The HeartSteps intervention consists of two sets of intervention components: (1) components intended to improve participants' affective associations with physical activity, including activity suggestions designed to to trigger positive feelings and associate them with being active, and prompts to bring their awareness to intrinsically motivating aspects of being active; and (2) components that target reflective self-regulatory processes, including graphs for self-monitoring, prompts to plan activity, and weekly activity goals. How exactly, and how much, participants will use HeartSteps will not be prescribed since our goal is to understand naturalistic trajectory of engagement with the intervention.

Studieoversigt

Status

Rekruttering

Betingelser

Intervention / Behandling

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

70

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

  • Navn: Pedja Klasnja, Ph.D. in Information Science
  • Telefonnummer: 734-763-3581
  • E-mail: klasnja@umich.edu

Studiesteder

    • Michigan
      • Ann Arbor, Michigan, Forenede Stater, 48109
        • Rekruttering
        • University of Michigan
        • Kontakt:
        • Underforsker:
          • Jessica Golbus, M.D.
        • Underforsker:
          • Brahmajee Nallamothu, M.D.
        • Underforsker:
          • Mark Newman, Ph.D.

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ingen

Køn, der er berettiget til at studere

Alle

Beskrivelse

Inclusion Criteria:

  • Must be a patient within the Michigan Medicine clinical system with data available in the electronic health record after January 1, 2020.

  • Age > 18

  • Owns and is a daily user of an Android or iPhone smartphone with study supported operating software.

  • Understands English to enable informed consent, completion of study-related surveys, and compliance with study notifications.

  • Will be completing within 30 days or have completed in the last 30 days the cardiac rehabilitation program at Michigan Medicine based on one of the following indications:

    • Coronary artery disease (including acute coronary syndromes and stable angina) following percutaneous coronary intervention (PCI)
    • Coronary artery disease following coronary artery bypass surgery (CABG)]
    • Valve repair or replacement (either surgical or percutaneous)
    • Coronary artery disease or an acute coronary syndrome not requiring revascularization

Exclusion Criteria:

  • Orthopedic or neurological condition limiting ability to actively engage in moderate intensity physical activity (e.g., brisk walking)
  • Greater than mild cognitive impairment
  • Wrist too large to wear an activity tracker comfortably. This will be assessed by asking participants "If they have ever had difficulty wearing a watch in the past due to the band being too small."
  • Currently receiving palliative care and/or in hospice care
  • Severe valvular stenosis or regurgitation
  • Unrevascularized left main coronary artery disease (> 50% obstruction on angiography) or proximal left anterior descending disease (>70% obstruction on angiography).
  • Exercise-induced ventricular tachycardia
  • Cardiac arrest within the prior 6 months
  • New York Heart Association (NYHA) class III or IV heart failure
  • Pulmonary arterial hypertension treated with inhaled or intravenous pulmonary hypertension-specific therapy
  • Ejection fraction <40%
  • Determined to be unsafe for participation in this program as assessed by a clinical nurse or investigative team.

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Støttende pleje
  • Tildeling: N/A
  • Interventionel model: Enkelt gruppeopgave
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Eksperimentel: Intervention

Participants receive the HeartSteps mHealth intervention for 3 months to support and increase physical activity. Components include:

  1. Activity Suggestions: Push notifications encouraging walks, randomized twice daily (probability 0.5).
  2. Morning Salience Messages: Notifications highlighting positive aspects of activity, randomized daily (probability 0.5).
  3. Planning Prompts: Notifications to plan next day's activity, randomized daily (probability 0.5).
  4. Weekly Reflection: Prompts each Sunday to reflect on past activity, set goals, and plan for the next week.
  5. Pull Interventions: In-app features like activity dashboards and planning tools.
  6. Ecological Momentary Assessments (EMA): Daily and weekly surveys on psychosocial constructs related to physical activity.

Participants wear a Fitbit Charge tracker to monitor activity, synced to their MyDataHelps account. The intervention aims to optimize engagement and physical activity levels.

HeartSteps is an innovative mobile health (mHealth) app designed for cardiac rehabilitation patients. The app features dynamic push notifications, daily and weekly surveys to capture psychosocial data, and an in-app dashboard that provides feedback on activity levels, goal progress, and reminders. Integrated with a Fitbit Charge tracker, HeartSteps emphasizes behavioral changes through engaging features. The intervention is personalized to meet individual needs and preferences, enhancing patient engagement and promoting sustained physical activity.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Weekly number of minutes of moderate to vigorous physical activity
Tidsramme: Baseline, 12 weeks

The primary outcome of the study is number of weekly minutes of moderate to vigorous physical activity (MVPA), as assessed by the Fitbit Charge 6 activity tracker.

Primary analysis will assess the difference in MVPA between the baseline week and the last (i.e. 12th) week of the study.

Baseline, 12 weeks

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
3-hour step count
Tidsramme: 12 weeks

Number of steps, as assessed by the Fitbit Charge 6 activity tracker, measured in the three-hour window following the randomization of activity suggestions.

This outcome will be assessed after each decision point for the micro-randomized activity suggestions. Each participant will have two decision points per day for the duration of the study.

12 weeks
Daily step count
Tidsramme: 12 weeks

Number of steps per day, assessed by the Fitbit Charge 6 activity tracker.

12 weeks
Affective exercise experiences (AFFEXX) scale
Tidsramme: Baseline, 12 weeks

A validated 36-item self-report instrument that assesses participants' affective associations with physical activity.

AFFEXX scale will be administered weekly for the duration of the study. The main analysis of this outcome will assess pre-post differences in the AFFEXX score between baseline and 12th week.

Baseline, 12 weeks

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

20. maj 2025

Primær færdiggørelse (Anslået)

1. februar 2027

Studieafslutning (Anslået)

1. februar 2027

Datoer for studieregistrering

Først indsendt

1. april 2025

Først indsendt, der opfyldte QC-kriterier

1. april 2025

Først opslået (Faktiske)

8. april 2025

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

25. september 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

22. september 2026

Sidst verificeret

1. september 2026

Mere information

Begreber relateret til denne undersøgelse

Yderligere relevante MeSH-vilkår

Andre undersøgelses-id-numre

  • HUM00269831
  • 5R01HL125440-07 (U.S. NIH-bevilling/kontrakt)

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

UBESLUTET

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner